NCT03079778 Transarterial Chemoembolization (TACE) With or Without Stereotactic Body Radiotherapy (SBRT) in Hepatocellular Carinoma Status WITHDRAWN Phase NA
NCT03066557 Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT03053596 LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry) Status COMPLETED Phase N/A
NCT03048123 HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B Status COMPLETED Phase PHASE2
NCT03047603 Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC Status COMPLETED Phase N/A
NCT03045497 Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads Status COMPLETED Phase PHASE1
NCT03042520 Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment Status UNKNOWN Phase N/A
NCT03035006 Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Status TERMINATED Phase PHASE1/PHASE2
NCT03033446 Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT03024684 Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03009461 Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis Status COMPLETED Phase PHASE2
NCT03007225 Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients Status COMPLETED Phase PHASE4
NCT03006926 A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma Status COMPLETED Phase PHASE1
NCT02997956 Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE) Status WITHDRAWN Phase PHASE1/PHASE2